For: | Bolognesi M, Di Pascoli M, Sacerdoti D. Clinical role of non-invasive assessment of portal hypertension. World J Gastroenterol 2017; 23(1): 1-10 [PMID: 28104976 DOI: 10.3748/wjg.v23.i1.1] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v23/i1/1.htm |
Number | Citing Articles |
1 |
Cosmas Rinaldi Adithya Lesmana, Maria Satya Paramitha, Rino A. Gani, Laurentius A. Lesmana. The role of endoscopic ultrasound for portal hypertension in liver cirrhosis. Journal of Medical Ultrasonics 2022; 49(3): 359 doi: 10.1007/s10396-021-01165-4
|
2 |
D. S. Karagiannakis, T. Voulgaris, S. I. Siakavellas, G. V. Papatheodoridis, J. Vlachogiannakos. Evaluation of portal hypertension in the cirrhotic patient: hepatic vein pressure gradient and beyond. Scandinavian Journal of Gastroenterology 2018; 53(10-11): 1153 doi: 10.1080/00365521.2018.1506046
|
3 |
Yang Hai, Weelic Chong, John R. Eisenbrey, Flemming Forsberg. Network Meta-Analysis: Noninvasive Imaging Modalities for Identifying Clinically Significant Portal Hypertension. Digestive Diseases and Sciences 2022; 67(7): 3313 doi: 10.1007/s10620-021-07168-y
|
4 |
Mohammed Farhaan Carrim, Mzamo Mbelle, Zwido Rabali, Robert Barasa Nyakoe, Didintle Mokgoko, Jarrod Zamparini. Non-cirrhotic portal hypertension in pregnancy due to schistosomiasis: A case series. Obstetric Medicine 2024; doi: 10.1177/1753495X241241833
|
5 |
Michael Esser, Michael Bitzer, Manuel Kolb, Jan Fritz, Mustafa Kurucay, Christer Ruff, Marius Horger. Correlation between acoustic radiation force impulse (ARFI)-based tissue elasticity measurements and perfusion parameters acquired by perfusion CT in cirrhotic livers: a proof of principle. Journal of Medical Ultrasonics 2019; 46(1): 81 doi: 10.1007/s10396-018-0886-x
|
6 |
Ana Petrisor, Razvan Peagu, Dumitru Cristinel Badiu, Ana Maria Alexandra Stanescu, Alexandru Constantin Moldoveanu, Carmen Fierbinteanu -Braticevici. Can Non-Invasive Methods Be Clinically Useful for Diagnosis and Severity of Portal Hypertension?. Hepatitis Monthly 2020; 20(5) doi: 10.5812/hepatmon.99974
|
7 |
Lei Miao, Giovanni Targher, Christopher D. Byrne, Luca Valenti, Xiaolong Qi, Ming‐Hua Zheng. Portal hypertension in nonalcoholic fatty liver disease: Challenges and perspectives. Portal Hypertension & Cirrhosis 2022; 1(1): 57 doi: 10.1002/poh2.8
|
8 |
Cosmas Rinaldi Adithya Lesmana, Monica Raharjo, Rino A. Gani. Managing liver cirrhotic complications: Overview of esophageal and gastric varices. Clinical and Molecular Hepatology 2020; 26(4): 444 doi: 10.3350/cmh.2020.0022
|
9 |
Shimaa Mahmoud El Sharawy, Mahmoud Zaki Elkadeem, Ibrahim Fathi Amer. The Predictors of Hepatorenal Syndrome Development in HCV Cirrhotic
Ascitic Egyptian Patients with Spontaneous Bacterial Peritonitis. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2023; 22(1): 58 doi: 10.2174/1871523022666230613160225
|
10 |
Muthukumarassamy Rajakannu, Audrey Coilly, Daniel Cherqui, Antonio Sa Cunha, Denis Castaing, René Adam, Didier Samuel, Eric Vibert. Liver stiffness-based model predicts hepatic venous pressure gradient in patients with liver disease. HPB 2022; 24(10): 1796 doi: 10.1016/j.hpb.2021.11.003
|
11 |
Yuan‐Qiang Lin, Bo Jiang, He‐Qun Li, Chun‐Xiang Jin, Hui Wang. Application of the Hepatic Transit Time (HTT) in Evaluation of Portal Vein Pressure in Gastroesophageal Varices Patients. Journal of Ultrasound in Medicine 2019; 38(9): 2305 doi: 10.1002/jum.14924
|
12 |
Cosmas Rinaldi Adithya Lesmana, Maria Satya Paramitha, Irsan Hasan, Andri Sanityoso Sulaiman, Rino Alvani Gani. Portal Hypertension in Non-alcoholic Fatty Liver Disease in the Era of Non-invasive Assessment. European Medical Journal 2021; : 80 doi: 10.33590/emj/21-00039
|
13 |
Wen-Bin Cai, Ji-Kai Yin, Qiao-ying Li, Yi-Lin Yang, Yun-You Duan, Li Zhang. The severity of portal hypertension by a non-invasive assessment: acoustic structure quantification analysis of liver parenchyma. BMC Medical Imaging 2022; 22(1) doi: 10.1186/s12880-022-00817-2
|
14 |
Jun Wang, Liang Zhang, Sai ming Cheng, Bo Li, Jialin Shen. The evaluation of portal hypertension in cirrhotic patients with spectral computed tomography. Acta Radiologica 2023; 64(3): 918 doi: 10.1177/02841851221101356
|
15 |
Antony P Zacharias, Rebecca Jeyaraj, Lise Hobolth, Flemming Bendtsen, Lise Lotte Gluud, Marsha Y Morgan. Carvedilol versus traditional, non-selective beta-blockers for adults with cirrhosis and gastroesophageal varices. Cochrane Database of Systematic Reviews 2018; 2018(10) doi: 10.1002/14651858.CD011510.pub2
|
16 |
Peter Deibert, Adhara Lazaro, Zoran Stankovic, Denise Schaffner, Martin Rössle, Wolfgang Kreisel. Beneficial long term effect of a phosphodiesterase-5-inhibitor in cirrhotic portal hypertension: A case report with 8 years follow-up. World Journal of Gastroenterology 2018; 24(3): 438-444 doi: 10.3748/wjg.v24.i3.438
|
17 |
Yanting Ye, Chao Xia, Hong Hu, Shihang Tang, Hui Huan. Metabolomics reveals altered metabolites in cirrhotic patients with severe portal hypertension in Tibetan population. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1404442
|
18 |
Adil S. MIR, Dario SORRENTINO. Non-cirrhotic portal hypertension in inflammatory bowel disease. Minerva Gastroenterology 2023; 69(2) doi: 10.23736/S2724-5985.20.02684-7
|
19 |
Vasyl I. Rusyn, Konstantin E. Rumiantsev, Andriy A. Rusyn, Olesia Balazh. COMPREHENSIVE TREATMENT OF COMPLICATED COURSE OF LIVER CIRRHOSIS IN CASE OF BLEEDING FROM THE VARICOS VEINS OF ESOPHAGUS, ENCEPHALOPATHY AND ASCITES. Emergency Medical Service 2022; 9(2): 162 doi: 10.36740/EmeMS202203104
|